UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm

International journal of molecular sciences, 2020-12, Vol.22 (1), p.75

2020

Volltextzugriff (PDF)

Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells

Nature communications, 2016-01, Vol.7 (1), p.10321-10321, Article 10321

2016

Volltextzugriff (PDF)

Immunogenicity Risk Profile of Nanobodies

Frontiers in immunology, 2021-03, Vol.12, p.632687

2021

Volltextzugriff (PDF)

Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery

Antibodies (Basel), 2019-01, Vol.8 (1), p.12

2019

Volltextzugriff (PDF)

Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy

Theranostics, 2018-01, Vol.8 (13), p.3559-3570

2018

Volltextzugriff (PDF)

Preclinical screening of anti‐HER2 nanobodies for molecular imaging of breast cancer

The FASEB journal, 2011-07, Vol.25 (7), p.2433-2446

2011

Volltextzugriff (PDF)

Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle

Expert opinion on biological therapy, 2016-08, Vol.16 (8), p.1035-1047

2016

Volltextzugriff (PDF)

Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade

Journal of Nuclear Medicine, 2021-11, Vol.62 (11), p.1638-1644

2021

Volltextzugriff (PDF)

Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody

Nature communications, 2023-02, Vol.14 (1), p.1062-1062, Article 1062

2023

Volltextzugriff (PDF)

Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions

Circulation research, 2012-03, Vol.110 (7), p.927-937

2012

Volltextzugriff (PDF)

Mechanisms Underlying Connexin Hemichannel Activation in Disease

International journal of molecular sciences, 2021-03, Vol.22 (7), p.3503

2021

Volltextzugriff (PDF)

Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties

International journal of molecular sciences, 2024-06, Vol.25 (11), p.5634

2024

Volltextzugriff (PDF)

Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma

Molecular cancer therapeutics, 2017-12, Vol.16 (12), p.2828-2839

2017

Volltextzugriff (PDF)

A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in mice

Diabetologia, 2020-04, Vol.63 (4), p.825-836

2020

Volltextzugriff (PDF)

In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells

Scientific reports, 2023-11, Vol.13 (1), p.18995-13, Article 18995

2023

Volltextzugriff (PDF)

Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide–Cysteine Chemistry

Pharmaceuticals (Basel, Switzerland), 2021-06, Vol.14 (6), p.550

2021

Volltextzugriff (PDF)

Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha

Frontiers in immunology, 2021-11, Vol.12, p.777524-777524

2021

Volltextzugriff (PDF)

Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation

Biomolecules (Basel, Switzerland), 2020-09, Vol.10 (10), p.1388

2020

Volltextzugriff (PDF)

Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT

Frontiers in immunology, 2023-09, Vol.14, p.1268900-1268900

2023

Volltextzugriff (PDF)

Nanobodies for the Early Detection of Ovarian Cancer

International journal of molecular sciences, 2022-11, Vol.23 (22), p.13687

2022

Volltextzugriff (PDF)

Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy

Pharmaceuticals (Basel, Switzerland), 2021-12, Vol.15 (1), p.13

2021

Volltextzugriff (PDF)

Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases

Pharmaceutics, 2019-08, Vol.11 (8), p.376

2019

Volltextzugriff (PDF)

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

Frontiers in immunology, 2024-04, Vol.15, p.1389018-1389018

2024

Volltextzugriff (PDF)

Surface display of a single-domain antibody library on Gram-positive bacteria

Cellular and molecular life sciences : CMLS, 2013-03, Vol.70 (6), p.1081-1093

2013

Volltextzugriff (PDF)

Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33

International journal of molecular sciences, 2020-01, Vol.21 (1), p.310

2020

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(208)
Mit Volltextzugriff
(188)

Publikationsform

Artikel
(232)
Buchkapitel
(2)

Sprache

Englisch
(234)

Erscheinungsjahr

n.n

Thema

Science & Technology
(141)
Life Sciences & Biomedicine
(131)
Humans
(90)
Animals
(86)
Mice
(70)
Female
(52)
Nanobodies
(47)
Nanobody
(46)
Cell Line, Tumor
(35)
Cancer
(33)
Tumors
(33)
Oncology
(30)
Radiology, Nuclear Medicine & Medical Imaging
(27)
Tissue Distribution
(27)
Antibodies
(26)
Biochemistry & Molecular Biology
(26)
Single-Domain Antibodies - Chemistry
(26)
Molecular Imaging
(24)
Breast Cancer
(23)
Single-Domain Antibodies - Immunology
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm

Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells

Immunogenicity Risk Profile of Nanobodies

Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery

Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy

Preclinical screening of anti‐HER2 nanobodies for molecular imaging of breast cancer

Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle

Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade

Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody

Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions

Mechanisms Underlying Connexin Hemichannel Activation in Disease

Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties

Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma

A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in mice

In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells

Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide–Cysteine Chemistry

Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha

Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation

Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT

Nanobodies for the Early Detection of Ovarian Cancer

Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy

Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

Surface display of a single-domain antibody library on Gram-positive bacteria

Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33

Suchergebnisse filtern